Neurogastrx is a privately held, late clinical-stage biopharmaceutical company focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) diseases, particularly erosive esophagitis and gastroparesis
Neurogastrx is a privately held, late clinical-stage biopharmaceutical company focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) diseases, particularly erosive esophagitis and gastroparesis.